
NSAID-related GI side effects result from inhibition of prostaglandins, which play a key role in maintaining the integrity of the gastric mucosa. The non-selective inhibition of the Cox enzymes result in an inhibition of systemic prostaglandin synthesis, which leads to an impairment of the GI mucosa, often resulting in ulceration and irritation. This places patients at increased risk for upper GI irritation, gastritis, GI bleeding and ultimately, duodenal and gastric ulcers.
![]() |
![]() |
|
In more than 80% of patients with serious GI complications, |
||
![]() |
![]() |
![]() |
![]() |
|
Patients taking NSAID's for prolonged periods are at risk for both mild and severe side effects including:
|
||
![]() |
![]() |
Clinical studies have shown that GI ulcers afflict 10-25% of chronic arthritis patients treated with NSAIDs, and arthritis patients are 2.5-5 times more likely to be hospitalized for NSAID related GI complications than the general population. In more than 80% of patients with these serious GI complications, there are no prior symptoms or warning signals.

Source:
Gabriel, et al. Annals Internal Medicine. 1991; 115-787.
Garcia, R. et al. Lancet. 1994; 343-769.
Silverstein et al. Annals Internal Medicine. 1995 ; 123-241.
Sorensen et al. Am J Gastroenterol. 2000;95:2218.